Shariat - Figure 43
High-Risk (HG Ta, T1, and/or Tis) NMIBC after restaging TUR + BCG Therapy (n=1021)
FIG. 43: Despite the previous conclusions, in this series of patients with T1 high-grade bladder cancer from Herr et al[61] (Figure), no BCG maintenance was given but patients were still treated with re-induction. A number of patients (20-30%) experienced disease recurrence and eventual disease progression.
References
[61]
Herr HW, Dalbagni G, Donat SM. Bacillus Calmette-Guérin without maintenance therapy for high-risk non–muscle-invasive bladder cancer. Eur Urol. 2011;60:32−6 http://dx.doi.org/10.1016/j.eururo.2011.03.051
